These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

57 related items for PubMed ID: 16472706

  • 21. [Targeted therapy in non-small cell lung tumors: recent findings and future perspectives].
    Conte PF, Barbieri F.
    Pathologica; 2005 Aug; 97(4):172-3. PubMed ID: 16440637
    [No Abstract] [Full Text] [Related]

  • 22. Recurrent small cell lung cancer: update.
    Glisson BS.
    Semin Oncol; 2003 Feb; 30(1):72-8. PubMed ID: 12635091
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.
    Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB, Leming PD, Spigel DR, Antonia SJ, Horn L, Drake CG, Pardoll DM, Chen L, Sharfman WH, Anders RA, Taube JM, McMiller TL, Xu H, Korman AJ, Jure-Kunkel M, Agrawal S, McDonald D, Kollia GD, Gupta A, Wigginton JM, Sznol M.
    N Engl J Med; 2012 Jun 28; 366(26):2443-54. PubMed ID: 22658127
    [Abstract] [Full Text] [Related]

  • 27. Optimizing therapy in previously treated non-small cell lung cancer.
    Miller VA.
    Semin Oncol; 2006 Feb 28; 33(1 Suppl 1):S25-31. PubMed ID: 16472706
    [Abstract] [Full Text] [Related]

  • 28. Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we go.
    Patel JD, Pasche B, Argiris A.
    Crit Rev Oncol Hematol; 2004 Jun 28; 50(3):175-86. PubMed ID: 15182824
    [Abstract] [Full Text] [Related]

  • 29. Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.
    Maione P, Gridelli C, Troiani T, Ciardiello F.
    Oncologist; 2006 Mar 28; 11(3):274-84. PubMed ID: 16549812
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Use of novel second-line targeted therapies in non-small cell lung cancer.
    Massarelli E, Herbst RS.
    Semin Oncol; 2006 Feb 28; 33(1 Suppl 1):S9-16. PubMed ID: 16472704
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we go.
    Patel JD, Pasche B, Argiris A.
    Crit Rev Oncol Hematol; 2004 Jun 28; 50(3):175-86. PubMed ID: 15182824
    [Abstract] [Full Text] [Related]

  • 34. Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC.
    Maione P, Gridelli C, Troiani T, Ciardiello F.
    Oncologist; 2006 Mar 28; 11(3):274-84. PubMed ID: 16549812
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Use of novel second-line targeted therapies in non-small cell lung cancer.
    Massarelli E, Herbst RS.
    Semin Oncol; 2006 Feb 28; 33(1 Suppl 1):S9-16. PubMed ID: 16472704
    [Abstract] [Full Text] [Related]

  • 37. Optimizing therapy in previously treated non-small cell lung cancer.
    Miller VA.
    Semin Oncol; 2006 Feb 28; 33(1 Suppl 1):S25-31. PubMed ID: 16472706
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.